Series B funding round for Strand Therapeutics raising $150M in August 2025
Series B funding round for Strand Therapeutics raising $150M in August 2025
| Investor | Firm Type | Partner |
|---|
KinnevikLEAD | Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Public | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Eli Lilly |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$253M
Top Valuation
-
Strand Therapeutics raised $150M in a Series B round.
The round was announced on 08/01/25.
The round was led by Kinnevik.